Phase 3 trial results demonstrate the superiority of long-acting injectable cabotegravir + rilpivirine over daily oral ...

Researchers reviewed the phase 3 findings of a TKI inhibitor treatment compared with aflibercept 2 mg for maintaining vision in patients with wet AMD.

Phase 3 results suggest intravenous vedolizumab is effective and safe for clinical remission in pediatric patients with moderate to severe UC.

Higher risk for gestational diabetes and some poor newborn outcomes reported, but lower risk for some adverse pregnancy outcomes also found.

GLP-1 RAs linked to increased risk for androgenetic alopecia, nonscarring hair loss, telogen effluvium at 6 months.

The US Food and Drug Administration (FDA) has announced a recall of more than 20,000 peanut butter products after pieces of plastic were found during the manufacturing process.

HealthDay News — A ketogenic diet (KD) may aid adults with treatment-resistant depression (TRD) in the short term, according to a study published online February 4 in JAMA Psychiatry.

Garetosmab is a fully-human monoclonal antibody designed to bind and neutralize Activin A, a major promoter of heterotopic ossification in patients with FOP.

HealthDay News — For women with functional hypothalamic amenorrhea (FHA), transdermal hormone replacement therapy (HRT) improves bone mineral density (BMD) at the lumbar spine (LS) and femoral neck ...

HealthDay News — Adequate staffing tops the list of factors that can help hospitals reattract the registered nurse (RN) workforce, according to a research letter published online February 9 in JAMA ...

Pivya ® (pivmecillinam tablets) is now available for the treatment of female patients aged 18 years and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of ...

The Food and Drug Administration (FDA) has approved Filkri ® (filgrastim-laha), a biosimilar to Neupogen ® (filgrastim). Filkri, a leukocyte growth factor, is approved to: ...